Related Experiment Videos

Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2

William B White1

  • 1Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut 06030-3940, USA. wwhite@nso1.uchc.edu

Blood Pressure Monitoring
|March 19, 2008
PubMed

Insights

For difficult-to-control hypertension, especially stage 2, combining multiple blood pressure (BP) medications is key. Combination therapy simplifies treatment, improves adherence, and reduces cardiovascular risks.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Poorly controlled blood pressure (BP) significantly increases cardiovascular disease (CVD) risk.
  • Specific populations like the elderly, African-Americans, and those with diabetes or kidney disease often present challenges in BP management.
  • Stage 2 hypertension (BP ≥160/100 mmHg) and comorbidities necessitate aggressive treatment strategies.

Purpose of the Study:

  • To highlight the benefits of combination antihypertensive therapy for achieving BP goals.
  • To emphasize the role of combination therapy in high-risk patient groups.
  • To support the use of combination therapy as an initial treatment strategy.

Main Methods:

  • Review of current data and treatment guidelines on antihypertensive therapy.
  • Analysis of the pathophysiologic mechanisms targeted by different drug classes.
  • Evaluation of the impact of combination therapy on BP control, adherence, and tolerability.

Main Results:

  • Over two-thirds of high-risk patients with stage 2 hypertension and all with diabetes or kidney disease require multiple antihypertensive agents.
  • Combining drugs with complementary actions addresses diverse pathophysiologic pathways, leading to more effective BP reduction.
  • Fixed-dose combinations simplify regimens, potentially improving patient adherence and BP control.

Conclusions:

  • Combination antihypertensive therapy is essential for achieving BP goals in high-risk patients.
  • This strategy offers improved efficacy, tolerability, and adherence compared to monotherapy.
  • Current guidelines recommend combination therapy as initial treatment for high-risk individuals with stage 2 hypertension.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...